Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Current Leases (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Current Leases data on record, last reported at $956000.0 in Q1 2026.

  • On a quarterly basis, Current Leases fell 6.73% to $956000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $956000.0, a 6.73% decrease, with the full-year FY2025 number at $1.1 million, down 4.1% from a year prior.
  • Current Leases reached $956000.0 in Q1 2026 per OLMA's latest filing, down from $1.1 million in the prior quarter.
  • Over the last five years, Current Leases for OLMA hit a ceiling of $1.2 million in Q4 2024 and a floor of $798000.0 in Q2 2023.
  • A 5-year average of $1.0 million and a median of $1.1 million in 2024 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: dropped 25.97% in 2023, then skyrocketed 38.22% in 2024.
  • Tracing OLMA's Current Leases over 5 years: stood at $1.0 million in 2022, then dropped by 2.66% to $988000.0 in 2023, then increased by 18.62% to $1.2 million in 2024, then dropped by 4.1% to $1.1 million in 2025, then dropped by 14.95% to $956000.0 in 2026.
  • Business Quant data shows Current Leases for OLMA at $956000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.